Back to Trades
Curran Terrie
DirectorCIK 0001690298
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 3
- Companies
- 1
- Active
- 2026
Curran Terrie, Director, has filed 3 SEC reports (2026), all concentrated in Arcutis Biotherapeutics, Inc. (ARQT), totaling $2.0M in disclosed volume. Weighing $0 bought versus $984.0K sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Aug 28 | ARQT Arcutis Biotherapeutics, Inc. | Curran Terrie | Director | Sell | $956.1K |
| Aug 24 | ARQT Arcutis Biotherapeutics, Inc. | Curran Terrie | Director | Sell | $27.9K |
| Jun 9 | ARQT Arcutis Biotherapeutics, Inc. | Curran Terrie | Director | Grant | $353.8K |
3 filings